Summary. The in vivo effects of 1,25-IOHI 2 Dg were assessed using fetuses from normal and thyroparathyroidectomized (TPTX) Introduction.
(-1.39 and -0.65 mg/dl, respectively), while no modification was found in fetuses from normal females. Therefore, the hypersensitivity of fetuses from TPTX mothers to 1,25-(OH) 2 D 3 was unrelated to the development of the fetal hyperparathyroidism secondary to maternal TPTX. The percentage of ash was unchanged in decapitated fetuses from TPTX mothers and was increased in intact littermates after 1,25-IOH1 2 D 3 treatment. However, these values for total ash may represent alterations in bones and/or soft tissues.
Introduction.
Few investigations have been done on the in vivo effects of 1,25-dihydroxyvitamin D 3 (1,25-IOH) Z D 3 ) administration to the fetus. In sheep fetuses one month before term, the injection of 1a-(OH)D 3 induced a rise in both plasma calcium and plasma phosphate levels (Barlet et al., 1978) . It is already known that fetal bones from thyroparathyroidectomized (TPTX) pregnant rats are more sensitive to the in vitro effects of 1,25-(OH1 2 D 3 (evaluated by 45 Ca-release in the medium) than fetal bones normal mothers (Rebut-Bonneton et al., 1983 (1956) . The data were presented as means ± SEM and the significance of differences between treated and control fetuses were evaluated using Student's t-test.
Results.
1. Effects of 7,.25-!OA/!D! injections on fetal plasma calcium and phosphate levels.
Fetuses from normal pregnant rats. -The decapitation of fetuses at 19.5 days of pregnancy had no effect on fetal plasma calcium and phosphate levels at 21.5 days of pregnancy ( fig. 1 ). Fetal injection of 1 pg of 1,25-·OH) Z D 3 /kg of body weight had no effect on body weight in either intact or decapitated fetuses 48 h later. An increase in plasma calcium level occurred only in decapitated fetuses (12.37 ± 0.38 vs 11.31 ± 0.25 mg/dl in untreated fetuses ; P < 0.05), whereas plasma phosphate levels were unchanged in both intact and decapitated fetuses (fig. 11. ) .
Fetuses from TPTX pregnant rats. -Plasma calcium levels at term were decreased in intact fetuses from TPTX mothers compared to those observed in intact fetuses from normal females (8.60 ± 0.23 vs 11.14 ± 0.21 mg/dl, respectively ; P < 0.001), whereas plasma phosphates were increased (13.28 ± 0.45 vs 11.27 ± 0.21 mg/dl, respectively ; P < 0.011. These data are in agreement with previously published results (Garel and Geloso-Meyer, 1971 ; Garel, Gilbert and Besnard, 1981 (Rebut-Bonneton, Garel and Delbarre, 1983) . This hypersensitivity was unrelated to the hyperparathyroid state secondary to maternal TPTX that occurred in these fetuses since fetal response to 1,25-(OH) 2 D 3 injections was not reduced in fetuses deprived of parathyroid glands by decapitation. However, the hypersensitivity might be due to the reduction in bone size secondary to the high weight loss observed in fetuses from TPTX females. The more marked effects of 1,25-(OH) 2 D 3 in decapitated than in intact fetuses (ACa : 3.66 and 2.01 mg/dl, respectively ; !P04 : -1.39 and &horbar; 0.65 mg/dl, respectively) might be explained by a lower plasma 1,25-(OH) 2 D 3 level in the former than in the latter ; it is well known that blood 1,25-(OH) 2 D 3 levels in adults are under the control of the parathyroid glands (Garabédian et a/., 1972) . The hypothesis of reduced blood levels of 1,25-(OH) 2 D 3 in fetuses from TPTX mothers might also be the cause of their hypersensitivity to this vitamin D 3 metabolite.
Our experiments provide indirect arguments in favor of the fetal hyperparathyroidism occurring in fetuses from TPTX pregnant rats because decapitation of 19.5-day old fetuses from these mothers induced at term a sharp decrease in plasma calcium level ( -2.37 mg/dl) and an increase in plasma phosphate (1.39 mg/dl). In contrast, both plasma calcium and phosphate levels were unchanged in decapitated fetuses from normal females. These data suggest that fetal parathyroid glands played a more important role in the control of fetal plasma calcium in TPTX than in normal rats. In normal rats, the fact that the plasma calcium levels in 21.5-day old fetuses decapitated 2 days before did not decrease confirms previously published data by Pic (1973) ; it is known that plasma calcium levels at term are reduced only if decapitation occurs before 19.5 days of pregnancy (Pic, 1973) . However, there is some indirect evidence that fetal parathyroid glands are involved in the control of fetal plasma calcium just before term (Pic, 1973 ; Garel, 1970 Garel, , 1975 
